论文部分内容阅读
目的探讨儿童病毒性上呼吸道感染患者给予抗病毒药物治疗的临床疗效。方法选取2013年3月至2014年3月我院儿童病毒性上呼吸道感染患者60例,以抽签法随机分为观察组与对照组,各30例。观察组患儿给予中药抗病毒药物治疗,对照组患儿给予西药治疗,比较两组患儿的临床疗效及用药安全性。结果观察组患儿的治疗总有效率为96.7%,明显高于对照组的76.7%,差异有统计学意义(P<0.05);两组患儿用药不良反应发生率比较,差异无统计学意义(P>0.05),且Ⅲ、Ⅳ级不良症状均未发生。结论中药抗病毒药物具有疗效可靠、安全性高等优势,更适用于儿童病毒性上呼吸道感染。
Objective To investigate the clinical efficacy of antiviral drugs in children with viral upper respiratory tract infection. Methods Sixty children with viral upper respiratory tract infection in our hospital from March 2013 to March 2014 were selected and divided randomly into observation group and control group by lottery. Children in the observation group were treated with Chinese antiviral drugs, while those in the control group were treated with western medicine. The clinical efficacy and safety of the two groups of children were compared. Results The total effective rate in treatment group was 96.7%, which was significantly higher than 76.7% in control group (P <0.05). There was no significant difference between the two groups in the incidence of adverse drug reactions (P> 0.05), and Ⅲ, Ⅳ grade adverse symptoms did not occur. Conclusion Chinese medicine antiviral drugs with reliable efficacy, high safety advantages, more suitable for children with viral upper respiratory tract infection.